Rosnet O, Bühring H J, deLapeyrière O, Beslu N, Lavagna C, Marchetto S, Rappold I, Drexler H G, Birg F, Rottapel R, Hannum C, Dubreuil P, Birnbaum D
Laboratory of Molecular Oncology, U.119 INSERM, Marseille, France.
Acta Haematol. 1996;95(3-4):218-23. doi: 10.1159/000203881.
FLT3 is a receptor tyrosine kinase of 130-55 kDa expressed on normal bone marrow stem and early progenitor cells and on leukemic blasts from patients with acute leukemias. The FLT3 ligand, FL, is a new cytokine which acts on hematopoietic progenitors in synergy with other cytokines. FLT3 transduces FL-mediated signal through interaction with a number of cytoplasmic substrates.
FLT3是一种130 - 55 kDa的受体酪氨酸激酶,在正常骨髓干细胞、早期祖细胞以及急性白血病患者的白血病原始细胞上表达。FLT3配体(FL)是一种新型细胞因子,它与其他细胞因子协同作用于造血祖细胞。FLT3通过与多种细胞质底物相互作用来转导FL介导的信号。